These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8970608)

  • 21. Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
    Lentine KL; Schnitzler MA; Xiao H; Brennan DC
    Trials; 2015 Aug; 16():365. PubMed ID: 26285695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts.
    Goh BK; Chedid MF; Gloor JM; Raghavaiah S; Stegall MD
    Transpl Immunol; 2012 Oct; 27(2-3):95-100. PubMed ID: 22813834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F; Zieroth S; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
    Gentile G; Somma C; Gennarini A; Mastroluca D; Rota G; Lacanna F; Locatelli B; Remuzzi G; Ruggenenti P
    Am J Nephrol; 2015; 41(1):16-27. PubMed ID: 25612603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
    Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
    Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monotherapy with anti-LFA-1 monoclonal antibody promotes long-term survival of rat islet xenografts.
    Tredget EB; Arefanian H; Gill RG; Rajotte RV; Rayat GR
    Cell Transplant; 2008; 17(6):599-608. PubMed ID: 18819248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction therapy in renal transplant recipients: how convincing is the current evidence?
    Wagner SJ; Brennan DC
    Drugs; 2012 Mar; 72(5):671-83. PubMed ID: 22439670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis.
    Barlow CW; Moon MR; Green GR; Gamberg P; Theodore J; Reitz BA; Robbins RC
    Transpl Int; 2001 Aug; 14(4):234-9. PubMed ID: 11512056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
    Trofe-Clark J; Reese PP; Patel HJ; Jakobowski D; Goral S; Doll SL; Abt PL; Bloom RD
    Transplantation; 2012 Sep; 94(5):506-12. PubMed ID: 22895613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Rabbit Antithymocyte Globulin on Acute and Chronic Active Antibody-Mediated Rejection After Kidney Transplantation.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Yagisawa T
    Transplant Proc; 2019 Oct; 51(8):2602-2605. PubMed ID: 31324482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alemtuzumab induction for retransplantation after primary transplant with alemtuzumab induction
.
    Descourouez JL; Jorgenson MR; Parajuli S; Mandelbrot DA; Leverson GE; Odorico JS; Redfield RR
    Clin Nephrol; 2020 Feb; 93(2):77-84. PubMed ID: 31670651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alemtuzumab induction in renal transplantation.
    Hanaway MJ; Woodle ES; Mulgaonkar S; Peddi VR; Kaufman DB; First MR; Croy R; Holman J;
    N Engl J Med; 2011 May; 364(20):1909-19. PubMed ID: 21591943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
    Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
    Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.
    Kim JM; Jang HR; Kwon CH; Huh WS; Kim GS; Kim SJ; Joh JW; Oh HY
    Transplant Proc; 2012 Jan; 44(1):167-70. PubMed ID: 22310606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
    Patel SJ; Knight RJ; Suki WN; Abdellatif A; Duhart BT; Krauss AG; Mannan S; Nezakatgoo N; Osama Gaber A
    Clin Transplant; 2011; 25(3):E250-6. PubMed ID: 21231963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of antibody induction therapy in the current era of kidney transplantation.
    Opelz G; Unterrainer C; Süsal C; Döhler B
    Nephrol Dial Transplant; 2016 Oct; 31(10):1730-8. PubMed ID: 27190386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of rabbit antithymocyte globulin in cardiac transplantation. Relationship of serum clearance rates to clinical outcome.
    Bieber CP; Griepp RB; Oyer PE; Wong J; Stinson EB
    Transplantation; 1976 Nov; 22(5):478-88. PubMed ID: 793103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM
    Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.